Ashok Aspatwar, Holger M. Becker, Nanda Kumar Parvathaneni, Milka Hammaren, Aleksandra Svorjova, Harlan Barker, . . . Jean-Yves Winum. (2018). Nitroimidazole-based inhibitors DTP338 and DTP348 are safe for zebrafish embryos and efficiently inhibit the activity of human CA IX in Xenopus oocytes. Taylor & Francis Group.
Chicago Style (17th ed.) CitationAshok Aspatwar, et al. Nitroimidazole-based Inhibitors DTP338 and DTP348 Are Safe for Zebrafish Embryos and Efficiently Inhibit the Activity of Human CA IX in Xenopus Oocytes. Taylor & Francis Group, 2018.
MLA (9th ed.) CitationAshok Aspatwar, et al. Nitroimidazole-based Inhibitors DTP338 and DTP348 Are Safe for Zebrafish Embryos and Efficiently Inhibit the Activity of Human CA IX in Xenopus Oocytes. Taylor & Francis Group, 2018.